Literature DB >> 15557747

Novel evidence suggesting Clostridium difficile is present in human gut microbiota more frequently than previously suspected.

Masahiro Iizuka1, Shiho Konno, Hiroaki Itou, Junichi Chihara, Itaru Toyoshima, Yasuo Horie, Kenji Sasaki, Akiko Sato, Kenichi Shindo, Sumio Watanabe.   

Abstract

Prevalence rate of Clostridium difficile in healthy human adults is believed to be very low. Our RT-PCR system using glass powder, which can eliminate PCR inhibitors, detected C. difficile toxin B mRNA in 16 of 30 fecal samples (53.3%) from healthy human adults. In contrast, we failed to detect toxin B in the same fecal samples by PCR using DNA templates extracted with phenol-chloroform. Our results suggest that PCR inhibitors in feces carried through phenol-chloroform extraction procedure might suppress the sensitivity of PCR and that C. difficile is actually present in human gut microbiota more frequently than previously suspected.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15557747     DOI: 10.1111/j.1348-0421.2004.tb03607.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  Quantification of Clostridium difficile in antibiotic-associated-diarrhea patients.

Authors:  Paul Naaber; Jelena Stsepetova; Imbi Smidt; Merle Rätsep; Siiri Kõljalg; Krista Lõivukene; Liis Jaanimäe; Iren H Löhr; Olav B Natås; Kai Truusalu; Epp Sepp
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

2.  Distal gut microbiota of adolescent children is different from that of adults.

Authors:  Richard Agans; Laura Rigsbee; Harshavardhan Kenche; Sonia Michail; Harry J Khamis; Oleg Paliy
Journal:  FEMS Microbiol Ecol       Date:  2011-06-01       Impact factor: 4.194

3.  Longitudinal study of Clostridium difficile shedding in raccoons on swine farms and conservation areas in Ontario, Canada.

Authors:  Kristin J Bondo; J Scott Weese; Joyce Rouseau; Claire M Jardine
Journal:  BMC Vet Res       Date:  2015-10-07       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.